Shopping Cart
Remove All
Your shopping cart is currently empty
CMK, an RSK2 kinase inhibitor, shows similar potency but less chemical stability compared with FMK.


| Description | CMK, an RSK2 kinase inhibitor, shows similar potency but less chemical stability compared with FMK. |
| In vitro | CMK inhibits the growth of Cdc5 (L158G) with an IC50 of 36 nM, significantly more effective than its action on wild type Cdc5 (>30 μM). It causes a concentration-dependent first cell cycle mitotic arrest in the cdc5-as1 strain (IC50: 1.1 μM) and leads to anaphase arrest and delay in anaphase spindle migration. |
| Molecular Weight | 358.82 |
| Formula | C18H19ClN4O2 |
| Cas No. | 821794-90-5 |
| Relative Density. | 1.39 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 150 mg/mL (418.04 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween-80+45% Saline: 3.3 mg/mL (9.2 mM), Sonication is recommeded. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.